SCHRODER INVESTMENT MANAGEMENT GROUP - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,727,582
-37.6%
205,420
-6.8%
0.00%
-25.0%
Q2 2023$2,769,254
-37.3%
220,482
-17.8%
0.00%
-42.9%
Q1 2023$4,415,739
+24.1%
268,108
+12.5%
0.01%
+16.7%
Q4 2022$3,559,335
+7.8%
238,242
+61.4%
0.01%
+20.0%
Q3 2022$3,303,000
+15.0%
147,636
-13.7%
0.01%
+25.0%
Q2 2022$2,873,000
+10.7%
171,136
+102.2%
0.00%
+33.3%
Q1 2022$2,595,00084,6450.00%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 4,068,574$68,149,0005.76%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$467,408,0003.71%
BVF INC/IL 4,384,805$73,445,0003.55%
Boxer Capital, LLC 2,669,132$44,708,0002.83%
Nextech Invest Ltd. 475,485$7,964,0002.69%
EcoR1 Capital, LLC 3,723,541$62,369,0002.15%
HARBOURVEST PARTNERS LLC 296,402$4,965,0001.63%
Integral Health Asset Management, LLC 436,262$7,307,0001.50%
Alphabet Inc. 1,568,753$26,277,0001.43%
Fernwood Investment Management, LLC 185,063$3,100,0001.34%
View complete list of RELAY THERAPEUTICS INC shareholders